181 related articles for article (PubMed ID: 8790212)
1. Accelerated thyrotoxicosis induced by iodinated contrast media in metastatic differentiated thyroid carcinoma.
Lorberboym M; Mechanick JI
J Nucl Med; 1996 Sep; 37(9):1532-5. PubMed ID: 8790212
[TBL] [Abstract][Full Text] [Related]
2. Thallium-201 and iodine-131 scintigraphy in differentiated thyroid carcinoma.
Lorberboym M; Murthy S; Mechanick JI; Bergman D; Morris JC; Kim CK
J Nucl Med; 1996 Sep; 37(9):1487-91. PubMed ID: 8790199
[TBL] [Abstract][Full Text] [Related]
3. Relationship among 201T1 uptake, nuclear DNA content and clinical behavior in metastatic thyroid carcinoma.
Nakada K; Katoh C; Morita K; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Tamaki N
J Nucl Med; 1999 Jun; 40(6):963-7. PubMed ID: 10452311
[TBL] [Abstract][Full Text] [Related]
4. [Iodine-induced T3 hyperthyroidism in metastatic follicular thyroid cancer].
Ehrenheim C; Heintz P; Schober O; Schicha H; Hundeshagen H
Nuklearmedizin; 1986 Oct; 25(5):201-4. PubMed ID: 3797260
[TBL] [Abstract][Full Text] [Related]
5. Differentiated thyroid cancer presenting with thyrotoxicosis due to functioning metastases.
Haq M; Hyer S; Flux G; Cook G; Harmer C
Br J Radiol; 2007 Feb; 80(950):e38-43. PubMed ID: 17495053
[TBL] [Abstract][Full Text] [Related]
6. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
7. Severe thyrotoxicosis due to functioning pulmonary metastases of well-differentiated thyroid cancer.
Salvatori M; Saletnich I; Rufini V; Dottorini ME; Corsello SM; Troncone L; Shapiro B
J Nucl Med; 1998 Jul; 39(7):1202-7. PubMed ID: 9669394
[TBL] [Abstract][Full Text] [Related]
8. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
[TBL] [Abstract][Full Text] [Related]
9. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases.
Unal S; Menda Y; Adalet I; Boztepe H; Ozbey N; Alagöl F; Cantez S
J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579
[TBL] [Abstract][Full Text] [Related]
10. Iodide-induced thyrotoxicosis in a thyroidectomized patient with metastatic thyroid carcinoma.
Yoshinari M; Tokuyama T; Okamura K; Sato K; Kusuda K; Fujishima M
Cancer; 1988 Apr; 61(8):1674-8. PubMed ID: 3349427
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous metastasis from follicular carcinoma of the thyroid gland.
Caron P; Moreau-Cabarrot A; Gorguet B; Bazex J
Thyroid; 1993; 3(3):235-7. PubMed ID: 8257865
[TBL] [Abstract][Full Text] [Related]
12. Metastatic follicular carcinoma of the thyroid: reappearance of radioiodine uptake.
Oyen WJ; Mudde AH; van den Broek WJ; Corstens FH
J Nucl Med; 1995 Apr; 36(4):613-5. PubMed ID: 7699452
[TBL] [Abstract][Full Text] [Related]
13. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
Feine U; Lietzenmayer R; Hanke JP; Held J; Wöhrle H; Müller-Schauenburg W
J Nucl Med; 1996 Sep; 37(9):1468-72. PubMed ID: 8790195
[TBL] [Abstract][Full Text] [Related]
14. Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma.
Nakada K; Katoh C; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Itoh K; Tamaki N
J Nucl Med; 1998 May; 39(5):807-10. PubMed ID: 9591580
[TBL] [Abstract][Full Text] [Related]
15. Thallium-201 uptake with negative iodine-131 scintigraphy and serum thyroglobulin in metastatic oxyphilic papillary thyroid carcinoma.
Harder W; Lind P; Molnar M; Mikosch P; Gomez I; Gallowitsch HJ; Kresnik E; Unterweger O; Dinges HP
J Nucl Med; 1998 Feb; 39(2):236-8. PubMed ID: 9476925
[TBL] [Abstract][Full Text] [Related]
16. Total-body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer.
Carril JM; Quirce R; Serrano J; Banzo I; Jiménez-Bonilla JF; Tabuenca O; Barquín RG
J Nucl Med; 1997 May; 38(5):686-92. PubMed ID: 9170428
[TBL] [Abstract][Full Text] [Related]
17. Unusual metastatic spread of follicular thyroid carcinoma: report of a case.
Kelessis NG; Prassas EP; Dascalopoulou DV; Apostolikas NA; Tavernaraki AP; Vassilopoulos P PP
Surg Today; 2005; 35(4):300-3. PubMed ID: 15815846
[TBL] [Abstract][Full Text] [Related]
18. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
19. Unresectable huge sternal and mediastinal metastasis of follicular thyroid carcinoma; radiotherapy as first-line and palliative therapy.
Nar Demirer A; Ayturk S; Tutuncu NB; Gursoy A; Pak Y; Demirag NG
Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):155-8. PubMed ID: 18561094
[TBL] [Abstract][Full Text] [Related]
20. Metastatic follicular thyroid carcinoma to the kidney: a case report.
Garcia-Sanchis L; Lopez-Aznar D; Oltra A; Rivas A; Alonso J; Montalar J; Mateo A
Clin Nucl Med; 1999 Jan; 24(1):48-50. PubMed ID: 9890493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
